Back to top
more

Teleflex (TFX)

(Delayed Data from NYSE)

$115.89 USD

115.89
642,835

-3.61 (-3.02%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $115.89 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why Teleflex (TFX) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Here's Why Teleflex (TFX) is a Strong Growth Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Why Teleflex (TFX) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook

by Zacks Equity Research

TFX benefits from a diversified product portfolio in the third quarter of 2024, with strength in the Vascular Access and Interventional segments.

Zacks Equity Research

Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Teleflex (TFX) Surpasses Q3 Earnings Estimates

by Zacks Equity Research

Teleflex (TFX) delivered earnings and revenue surprises of 3.25% and 0.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Glaukos (GKOS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Glaukos (GKOS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

TFX Stock to Gain From Launch of New Vascular Access Devices in Canada

by Zacks Equity Research

Teleflex launches the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada.

Zacks Equity Research

Earnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline

by Zacks Equity Research

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

TFX or EW: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TFX vs. EW: Which Stock Is the Better Value Option?

Zacks Equity Research

TFX vs. EW: Which Stock Is the Better Value Option?

by Zacks Equity Research

TFX vs. EW: Which Stock Is the Better Value Option?

Zacks Equity Research

TFX vs. EW: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

TFX vs. EW: Which Stock Is the Better Value Option?

Zacks Equity Research

Is Teleflex Stock a Smart Option for Your Portfolio Right Now?

by Zacks Equity Research

TFX instils optimism with its robust performance in the Interventional category and potential in Asia.

Zacks Equity Research

Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

TFX or PEN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TFX vs. PEN: Which Stock Is the Better Value Option?

Zacks Equity Research

Teleflex's (TFX) Titan SGS Stapler Showcases Positive Outcomes

by Zacks Equity Research

Teleflex (TFX) publishes an analysis of clinical data showcasing the Titan SGS Stapler's enhanced clinical outcomes and significant efficiency benefits.

Zacks Equity Research

TFX or EW: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TFX vs. EW: Which Stock Is the Better Value Option?

Zacks Equity Research

Align Technology (ALGN) Encounters Low ASP, FX Headwinds

by Zacks Equity Research

Align Technology's (ALGN) Clear Aligner ASP is facing a significant impact of unfavorable foreign exchange across multiple currencies.

Zacks Equity Research

Is Phibro (PAHC) Stock Worth Retaining in Your Portfolio Now?

by Zacks Equity Research

Phibro's (PAHC) Animal Health business, supported by the flourishing Vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.

Zacks Equity Research

TFX or EW: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TFX vs. EW: Which Stock Is the Better Value Option?

Zacks Equity Research

Why Teleflex (TFX) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Teleflex (TFX) Tops Q2 Earnings Estimates, Raises 2024 Outlook

by Zacks Equity Research

Teleflex's (TFX) diversified portfolio and global footprint have driven durable growth in the second quarter of 2024.

Zacks Equity Research

Compared to Estimates, Teleflex (TFX) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Teleflex (TFX) Q2 Earnings Surpass Estimates

by Zacks Equity Research

Teleflex (TFX) delivered earnings and revenue surprises of 2.70% and 1.79%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

What's in Store for These 4 MedTech Stocks in Q2 Earnings?

by Urmimala Biswas

Here is a sneak peek into how four MedTech companies, LH, BIO, TFX and BRKR, are expected to fare in their second-quarter results, slated to be released tomorrow.